Featured Research

from universities, journals, and other organizations

Electrical switch during labor could be faulty in overweight women

Date:
June 18, 2014
Source:
Monash University
Summary:
Researchers have identified an electrical switch in the muscle of the uterus that plays a key role in the progression into labor. Crucially, the discovery shows that women who are overweight have a faulty switch. The finding may explain why overweight women have a higher likelihood of irregular contractions and are more likely to require a caesarean section than other women.

Researchers have identified an electrical switch in the muscle of the uterus that plays a key role in the progression into labour.

Crucially, the discovery, published today in the journal Nature Communications, shows that women who are overweight have a faulty switch. The finding may explain why overweight women have a higher likelihood of irregular contractions and are more likely to require a caesarean section than other women.

It's well known that strong rhythmic contractions of the uterus are needed to allow the baby's head to dilate the cervix. However little was known about what controls these contractions until now.

The groundbreaking research from Monash University, the Royal Women's Hospital and the Hunter Medical Research Institute, show that a potassium ion channel called hERG in the uterus is responsible.

Acting as a powerful electrical brake, hERG works during pregnancy to suppress contractions and prevent premature labour. However, at the onset of labour a protein acts as a switch to turn hERG off, removing the brake and ensuring that labour can take place.

The team, led by Professor Helena Parkington from the School of Biomedical Sciences at Monash University, found that in overweight women the switch doesn't work, failing to turn hERG off.

"We've known for years that women who are overweight are much more likely to experience complications during pregnancy and labour -- but we didn't know why," Professor Parkington said.

"Pinpointing the mechanism is a major breakthrough, not only does it ensure a smooth pregnancy, but knowing when contractions kick in at more or less the right time, is crucial to our understanding of the labour process."

Figures from the Royal Women's Hospital show that over 50 per cent of Australian women are overweight or obese; including thirty five per cent of women aged 25-35. As a result, clinicians are seeing more pregnant women who are overweight. These women are far more likely to experience complications during labour and delivery and require medical intervention.

By analysing uterine muscle biopsies from 70 pregnant women, the team found striking differences between overweight women and those of a healthy weight.

Testing the electrical signals in small amounts of uterine tissue taken from women who had an elective caesarean before labour started and women who needed an emergency caesarean during their labour, proved that hERG was dysregulated in overweight women.

Professor Parkington said this is the first time that the brake and the protein controlling it have been identified in uterine muscle. The insight could help to reduce complications during pregnancy and labour in overweight women.

"Now we know what is responsible for malfunctioning labour in overweight women, we can look to develop treatments to correct the 'faulty' switch and ensure both safer pregnancies and labour for women and their babies," she said.

The next phase of the research will look at developing a safe, effective and specific treatment, for example a new drug that turns off the switch to allow labour to start and progress.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Helena C. Parkington, Janet Stevenson, Mary A. Tonta, Jonathan Paul, Trent Butler, Kaushik Maiti, Eng-Cheng Chan, Penelope M. Sheehan, Shaun P. Brennecke, Harold A. Coleman, Roger Smith. Diminished hERG K channel activity facilitates strong human labour contractions but is dysregulated in obese women. Nature Communications, 2014; 5 DOI: 10.1038/ncomms5108

Cite This Page:

Monash University. "Electrical switch during labor could be faulty in overweight women." ScienceDaily. ScienceDaily, 18 June 2014. <www.sciencedaily.com/releases/2014/06/140618100616.htm>.
Monash University. (2014, June 18). Electrical switch during labor could be faulty in overweight women. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/06/140618100616.htm
Monash University. "Electrical switch during labor could be faulty in overweight women." ScienceDaily. www.sciencedaily.com/releases/2014/06/140618100616.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins